Our inaugural Columbia Children's Health Innovation and Learning Day showcased the depth and breadth of research conducted by Columbia physician-scientists to improve the care of children.
Sebastián Riquelme, PhD is a pioneer in the growing field of immunometabolism, investigating how the processes that turn food into energy impact the outcome of infectious diseases.
Pediatric cardiologist Kimara Targoff, MD studies zebrafish, a freshwater species that has the uncanny ability to create new heart cells to repair injuries.
Columbia’s chief of pediatric critical care and hospital medicine, Hülya Bayır, MD, is researching ways to protect brain tissue and prevent disability or death, after a child suffers a head injury.
Dr. Josh Milner studies rare causes of common diseases such as atopic dermatitis. He uses a step by step diagnostic approach to determine if there is an underlying genetic cause.
Dr. Adolfo Ferrando and his lab members focus primarily on deciphering the mechanisms that lead to chemotherapy resistance and relapse in acute lymphoblastic leukemia.
When Dr. Wendy Chung identified the Olson children's rare disease, “It was like someone turned on the flashlight, and at least now we have a vision of how to move forward," says their mother Colleen.
Priyanka Ahimaz and other genetic counselors educate patients about genetic disorders and help them navigate the complexities of having a genetic diagnosis.
Monica Bhatia, MD, director of Columbia’s Pediatric Stem Cell Transplant Program, is participating in a trial evaluating gene editing as a curative treatment for patients with sickle cell disease.
Stephanie Lovinsky-Desir, MD researches disparities in health outcomes for underrepresented minorities and the link between air pollution exposure and physical activity patterns among young people.
Dr. Rebecca Hough is both a compassionate clinician and a lung biologist with a special interest in the molecular mechanisms of acute lung injury and acute respiratory distress syndrome (ARDS).
Columbia’s pediatric hematology/oncology/stem cell transplantation team is launching a groundbreaking program in pediatric neuro-oncology, the Brain Tumor Technology Research (BTTR) initiative.
Columbia researchers are exploring ways to repurpose drugs approved by the FDA for other conditions and existing experimental therapies in difficult-to-treat pediatric cancers.
Columbia's Dr. Prakash Satwani is researching ways to reduce immediate and late-stage complications in bone marrow transplantation for children with leukemia/lymphoma.